Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects

Documenti analoghi

• Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
  di: Juan Jin, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
  di: Biao Sun, et al.
  Pubblicazione: (2026)
• Pharmacokinetics and bioequivalence of two N‐acetylcysteine tablets in healthy Chinese volunteers under fasting and fed conditions
  di: Xianmiao Yin, et al.
  Pubblicazione: (2025)
• Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
  di: Zhaoyu Wang, et al.
  Pubblicazione: (2024)
• Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
  di: Pan Luo, et al.
  Pubblicazione: (2026)